BioSpace News Archive

Policy

I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China

I-Mab Biopharma announced that National Medical Products Administration (NMPA) approved its IND application for TJM2 to conduct clinical trials in patients with rheumatoid arthritis (RA).

November 14, 2019
·
2 min read
Seeing and Measuring Hepatobiliary Disease Using Artificial Intelligence, Presented by Perspectum at RSNA 2019

Perspectum will be showcasing the application of Artificial Intelligence in their FDA-cleared, quantitative imaging services — LiverMultiScan for liver tissue characterization and MRCP+ for biliary tree visualization — at RSNA’s annual meeting this year.

November 14, 2019
·
2 min read
Drug Development

Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET

Topline results expected before the end of Q1/2020

November 14, 2019
·
10 min read
Genetown

Ninety percent of breastfeeding moms returning to work are pumping

Breastfeeding has tremendous health benefits for both mom and baby and is strongly encouraged by the World Health Organization and the American Academy of Pediatrics.

November 14, 2019
·
2 min read
Business

ThermoGenesis Holdings To Postpone Third Quarter 2019 Earnings Release And Conference Call Until Tuesday November 19, 2019

ThermoGenesis Holdings, Inc. formerly known as Cesca Therapeutics Inc. announced it will delay its third quarter ended September 30, 2019 earnings release and subsequent earnings conference call, previously scheduled for today to Tuesday, November 19, 2019.

November 14, 2019
·
2 min read
Business

Zosano Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateConference call scheduled for 1:30 pm PT today

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2019, as well as recent business highlights.

November 14, 2019
·
7 min read
Business

Viela Bio Reports Third Quarter 2019 Financial Results and Business Highlights

Viela Bio reported financial results and provided program highlights for the third quarter ended September 30, 2019.

November 14, 2019
·
10 min read
Biotech Beach

Heron Therapeutics to Present at the Jefferies London Healthcare Conference

Heron Therapeutics, Inc. announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the Jefferies London Healthcare Conference on Thursday, November 21, 2019 at 5:20 p.m. GMT at the Waldorf Hilton London hotel.

November 14, 2019
·
1 min read
FDA

Tricida Announces FDA Acceptance of New Drug Application for Veverimer

The FDA has assigned a Prescription Drug User Fee Act goal date of August 22, 2020 and indicated that it is currently planning to hold a Cardiovascular and Renal Drugs Advisory Committee meeting to discuss the application.

November 14, 2019
·
4 min read
Pharm Country

BD to Present at Jefferies 2019 London Healthcare Conference

BD announced that it will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019, at 6:20 a.m. ET.

November 14, 2019
·
1 min read